Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa

被引：0
|
作者：
Daniel Tobias Michaeli
Sophia Stoycheva
Simon Mashudu Marcus
Wenjia Zhang
Julia Caroline Michaeli
Thomas Michaeli
机构：
[1] Heidelberg University,Fifth Department of Medicine, University Hospital Mannheim
[2] Heidelberg University,Department of Personalized Oncology, University Hospital Mannheim
[3] London School of Economics and Political Science,Department of Health Policy
[4] Pfizer Inc,Health Economics and Outcomes Research
[5] Homerton University Hospital NHS Trust,Department of Obstetrics and Gynecology
[6] Asklepios-Clinic Hamburg-Altona,Division of Personalized Medical Oncology
[7] Asklepios Hospital Group,Department of Family Medicine and Primary Care, School of Clinical Medicine, Faculty of Health Science
[8] German Cancer Research Center (DKFZ),undefined
[9] University of the Witwatersrand,undefined
来源：
Clinical Drug Investigation | 2022年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 343
页数：10
相关论文
共 50 条
  • [1] Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
    Michaeli, Daniel Tobias
    Stoycheva, Sophia
    Marcus, Simon Mashudu
    Zhang, Wenjia
    Michaeli, Julia Caroline
    Michaeli, Thomas
    [J]. CLINICAL DRUG INVESTIGATION, 2022, 42 (04) : 333 - 343
  • [2] Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
    Palmer, Cody
    Dolk, Christiaan
    Sabale, Ugne
    Wang, Wei
    Saxena, Kunal
    [J]. EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 312 - 323
  • [3] COST-EFFECTIVENESS OF QUADRIVALENT HPV VACCINATION IN FINLAND
    Vaananen, J. J. P.
    Herse, F.
    Korkeamaki, J.
    Parvinen, P. M. T.
    Remy, O.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A431 - A431
  • [4] The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
    Ke Zhu
    Yuke Tian
    Xiaomei Dong
    Babatunde O. Akinwunmi
    Casper J. P. Zhang
    Jian Huang
    Wai-kit Ming
    [J]. Archives of Gynecology and Obstetrics, 2022, 306 : 173 - 187
  • [5] The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
    Zhu, Ke
    Tian, Yuke
    Dong, Xiaomei
    Akinwunmi, Babatunde O.
    Zhang, Casper J. P.
    Huang, Jian
    Ming, Wai-kit
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (01) : 173 - 187
  • [6] THE ESTIMATED IMPACT AND COST-EFFECTIVENESS OF NONAVALENT HPV VACCINATION IN THE UNITED STATES
    Chesson, H. W.
    Markowitz, L. E.
    Hariri, S.
    Ekwueme, D. U.
    Saraiya, M.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A61 - A62
  • [7] The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia
    de Boer, Pieter T.
    Kelso, Joel K.
    Haider, Nilimesh
    Thi-Phuong-Lan Nguyen
    Moyes, Jocelyn
    Cohen, Cheryl
    Barr, Ian G.
    Postma, Maarten J.
    Milne, George J.
    [J]. VACCINE, 2018, 36 (07) : 997 - 1007
  • [8] Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle income country setting
    Termrungruanglert, Wichai
    Vasuratna, Apichai
    Khemapech, Nipon
    Havanond, Piyalamporn Havanond
    Tantitamit, Tanitra
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A57 - A57
  • [9] Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia
    Wondimu, Abrham
    Postma, Maarten J.
    van Hulst, Marinus
    [J]. VACCINE, 2022, 40 (14) : 2161 - 2167
  • [10] Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
    Olsen, Jens
    Jepsen, Martin Rudbeck
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (02) : 183 - 191
12345